VANGUARD GROUP INC - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 59 filers reported holding FORTRESS BIOTECH INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$1,526,558
-47.2%
5,258,555
+0.1%
0.00%
Q2 2023$2,888,850
-32.7%
5,252,455
+0.3%
0.00%
Q1 2023$4,292,788
+28.4%
5,235,107
+2.6%
0.00%
Q4 2022$3,343,387
-23.8%
5,104,407
-0.0%
0.00%
Q3 2022$4,390,000
+1.9%
5,104,800
-0.5%
0.00%
Q2 2022$4,310,000
-44.2%
5,131,708
-9.6%
0.00%
Q1 2022$7,718,000
-45.7%
5,674,538
-0.3%
0.00%
Q4 2021$14,226,000
-18.1%
5,690,274
+5.5%
0.00%
Q3 2021$17,372,000
-9.4%
5,395,078
+0.4%
0.00%
Q2 2021$19,180,000
+5.6%
5,372,743
+4.5%
0.00%
Q1 2021$18,156,000
+25.4%
5,143,508
+12.6%
0.00%
Q4 2020$14,481,000
+9.6%
4,568,176
+39.6%
0.00%
Q3 2020$13,216,000
+119.1%
3,271,387
+45.3%
0.00%
Q2 2020$6,032,000
+77.5%
2,250,941
+25.1%
0.00%
Q1 2020$3,399,000
-20.3%
1,798,888
+8.4%
0.00%
Q4 2019$4,266,000
+72.2%
1,659,835
-5.5%
0.00%
Q3 2019$2,478,000
-21.8%
1,757,210
-16.8%
0.00%
Q2 2019$3,169,000
+39.7%
2,112,586
+65.8%
0.00%
Q1 2019$2,268,000
+142.8%
1,274,072
+17.3%
0.00%
Q4 2018$934,000
-53.2%
1,085,825
-13.0%
0.00%
Q3 2018$1,997,000
-45.1%
1,248,040
+2.2%
0.00%
Q2 2018$3,640,000
-33.7%
1,221,648
+1.3%
0.00%
Q1 2018$5,487,000
+11.9%
1,205,859
-1.9%
0.00%
Q4 2017$4,902,000
-7.1%
1,228,683
+3.0%
0.00%
Q3 2017$5,274,000
-14.0%
1,193,273
-7.6%
0.00%
Q2 2017$6,132,000
+18.6%
1,290,960
-7.6%
0.00%
Q1 2017$5,170,000
+44.0%
1,397,435
+5.1%
0.00%
Q4 2016$3,591,000
-9.8%
1,329,833
-0.8%
0.00%
Q3 2016$3,982,000
+10.0%
1,340,656
-0.4%
0.00%
Q2 2016$3,619,000
-6.9%
1,345,439
+7.3%
0.00%
Q1 2016$3,888,000
+11.1%
1,254,1970.0%0.00%
Q4 2015$3,499,000
-97.6%
1,254,197
-81.4%
0.00%
-100.0%
Q3 2015$147,385,000
+3515.9%
6,752,730
+456.6%
0.01%
Q2 2015$4,076,0001,213,2790.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q3 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,750,000$12,075,0002.26%
Nantahala Capital Management 8,140,794$26,213,0000.83%
SHIKIAR ASSET MANAGEMENT INC 694,500$2,236,0000.63%
PERKINS CAPITAL MANAGEMENT INC 128,805$415,0000.26%
Telemetry Investments, L.L.C. 55,000$177,0000.24%
CPWM, LLC 514,767$1,658,0000.15%
GSA CAPITAL PARTNERS LLP 187,178$603,0000.06%
Spotlight Asset Group, Inc. 10,700$34,0000.02%
Summit Global Investments 44,900$145,0000.01%
Virtu Financial LLC 25,714$83,0000.01%
View complete list of FORTRESS BIOTECH INC shareholders